Russell Investments Group Ltd. grew its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 40.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,127 shares of the company's stock after buying an additional 6,084 shares during the quarter. Russell Investments Group Ltd. owned 0.14% of Chemed worth $11,193,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Chemed during the fourth quarter valued at $95,872,000. Raymond James Financial Inc. bought a new position in Chemed during the fourth quarter valued at approximately $42,023,000. Principal Financial Group Inc. boosted its stake in shares of Chemed by 114.1% in the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock worth $39,554,000 after buying an additional 39,791 shares during the last quarter. Segall Bryant & Hamill LLC purchased a new stake in Chemed during the fourth quarter valued at $12,880,000. Finally, Boston Trust Walden Corp grew its stake in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock valued at $128,303,000 after purchasing an additional 22,105 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.32% of the company's stock.
Chemed Trading Down 1.6 %
NYSE CHE traded down $9.68 on Tuesday, reaching $591.01. 64,680 shares of the stock were exchanged, compared to its average volume of 97,194. The company's 50-day simple moving average is $583.92 and its two-hundred day simple moving average is $567.73. Chemed Co. has a one year low of $512.12 and a one year high of $625.09. The firm has a market capitalization of $8.64 billion, a PE ratio of 29.86, a PEG ratio of 2.15 and a beta of 0.49.
Chemed Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is currently 10.05%.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. Royal Bank of Canada increased their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.
View Our Latest Report on Chemed
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.